ERAS in Gastrointerstinal Fistulas.

Sponsor
Stanley Dudrick's Memorial Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04771832
Collaborator
(none)
100
1
120
0.8

Study Details

Study Description

Brief Summary

An enterocutaneous fistula (ECF) poses a major surgical problem. The definitive surgical repair of persistent fistulas remains a surgical challenge with a high rate of re-fistulation and mortality, and the reasons for that is not the surgical technique alone. Enhanced Recovery after Surgery (ERASĀ®) is an evidence-based multimodal perioperative protocol proven to reduce postoperative complications. The aim of the study was to assess the clinical value of ERAS protocol in surgical patients with ECF.

Condition or Disease Intervention/Treatment Phase
  • Procedure: ERAS

Detailed Description

ERAS protocol was used in all patients scheduled for surgery for ECF at the Stanley Dudrick's Memorial Hospital in Skawina between 2011 and 2020. A multidisciplinary team (MDT) was in charge of the program and performed annual audits. A consecutive series of 100 ECF patients (44 F, 56 M, mean age 54.1) was evaluated. Postoperative complications rate, readmission rate, length of hospital stay, prevalence of postoperative nausea and vomiting were assessed.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
100 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Enhanced Recovery After Surgery (ERAS) Protocol is a Safe and Effective Approach in Patients With Gastrointestinal Fistulas Undergoing Reconstruction: Results From a Prospective Study.
Actual Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
ERAS

Perioperative care with Enhanced Recovery After Surgery (ERAS) protocol

Procedure: ERAS
Enhanced Recovery After Surgery (ERAS) protocol is an evidence-based multimodal perioperative protocol focused on stress reduction and the promotion of a return to function

Outcome Measures

Primary Outcome Measures

  1. Postoperative complications [up to 24 weeks]

    Any surgical complications

  2. length of hospital stay [up to 24 weeks]

    duration of hospitalization

  3. postoperative nausea and vomiting [up to 24 weeks]

    prevalence of postoperative nausea and vomiting

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • surgery for gastrointestinal fistula
Exclusion Criteria:
  • conservative treatment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanley Dudrick's Memorial Hospital Skawina Poland 32-050

Sponsors and Collaborators

  • Stanley Dudrick's Memorial Hospital

Investigators

  • Principal Investigator: Stanislaw Klek, PhD, Stanley Dudrick's Memorial Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stanislaw Klek, Head of the Unit, Stanley Dudrick's Memorial Hospital
ClinicalTrials.gov Identifier:
NCT04771832
Other Study ID Numbers:
  • ERASGI
First Posted:
Feb 25, 2021
Last Update Posted:
Feb 25, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 25, 2021